levofloxacin has been researched along with vinorelbine in 5 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (vinorelbine) | Trials (vinorelbine) | Recent Studies (post-2010) (vinorelbine) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 50 | 0 | 31 |
| Protein | Taxonomy | levofloxacin (IC50) | vinorelbine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 1.35 | |
| Cholinesterase | Homo sapiens (human) | 0.7 | |
| Tubulin beta chain | Homo sapiens (human) | 1.35 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 1 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.35 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Substance-K receptor | Homo sapiens (human) | 1.6062 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for levofloxacin and vinorelbine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for levofloxacin and vinorelbine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |